生物技术领域的结构基因组学。

Nature Structural Biology Pub Date : 2000-11-01 DOI:10.1038/80718

S Dry, S McCarthy, T Harris

{"title":"生物技术领域的结构基因组学。","authors":"S Dry, S McCarthy, T Harris","doi":"10.1038/80718","DOIUrl":null,"url":null,"abstract":"Commercial efforts in structural genomics focus on providing to pharmaceutical customers information that relates to the suitability of specific proteins as drug targets and the informed selection and refinement of lead compounds generated by high-throughput screening and rational approaches. These efforts follow a variety of business models and are impacted by activities in the public domain, recent technological advances, and the changing intellectual property landscape.","PeriodicalId":18848,"journal":{"name":"Nature Structural Biology","volume":"7 Suppl ","pages":"946-9"},"PeriodicalIF":0.0000,"publicationDate":"2000-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1038/80718","citationCount":"29","resultStr":"{\"title\":\"Structural genomics in the biotechnology sector.\",\"authors\":\"S Dry, S McCarthy, T Harris\",\"doi\":\"10.1038/80718\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Commercial efforts in structural genomics focus on providing to pharmaceutical customers information that relates to the suitability of specific proteins as drug targets and the informed selection and refinement of lead compounds generated by high-throughput screening and rational approaches. These efforts follow a variety of business models and are impacted by activities in the public domain, recent technological advances, and the changing intellectual property landscape.\",\"PeriodicalId\":18848,\"journal\":{\"name\":\"Nature Structural Biology\",\"volume\":\"7 Suppl \",\"pages\":\"946-9\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2000-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1038/80718\",\"citationCount\":\"29\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Nature Structural Biology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1038/80718\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nature Structural Biology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1038/80718","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 29

摘要

结构基因组学的商业努力侧重于向制药客户提供与特定蛋白质作为药物靶点的适用性有关的信息，以及通过高通量筛选和合理方法产生的先导化合物的明智选择和改进。这些努力遵循各种商业模式，并受到公共领域活动、最新技术进步和不断变化的知识产权格局的影响。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

Structural genomics in the biotechnology sector.

Commercial efforts in structural genomics focus on providing to pharmaceutical customers information that relates to the suitability of specific proteins as drug targets and the informed selection and refinement of lead compounds generated by high-throughput screening and rational approaches. These efforts follow a variety of business models and are impacted by activities in the public domain, recent technological advances, and the changing intellectual property landscape.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Nature Structural Biology

自引率

0.00%

发文量

期刊最新文献

Hardware and software Structural aspects of protein synthesis Starting off right Incorporation of aminoacyl-tRNA into the ribosome as seen by cryo-electron microscopy Protein structure modeling for structural genomics.